Marketlooks: Prescription Generic Cardiovascular DrugsMarketLooks - Kalorama InformationNovember 1, 2002 16 Pages - SKU: MLK834235 |
|
The World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices)
5/8/2013 | published by: Kalorama Information
The World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices)
Catheters make it possible to drain or inject fluids or enable access to the body
|
read more...
|
$3,500.00
|
|
Oman Pharmaceuticals and Healthcare Report Q3 2013
5/29/2013 | published by: Business Monitor International
BMI View: Although one of the smallest healthcare markets in the Gulf Cooperation Council, Oman boastsa 10-year compound annual growth rate of 9% in US dollar terms, a figure in line with large regionalplayers Saudi
|
read more...
|
$1,295.00
|
|
Singapore Pharmaceuticals and Healthcare Report Q3 2013
5/29/2013 | published by: Business Monitor International
BMI View: Unlike other developed Asia Pacific countries, we note that the Singaporean government isseeking to increase its share of healthcare expenditure in light of the ageing population's rising demand forhealthcare. Such commitment provides growth
|
read more...
|
$1,295.00
|
|
China Medicine Production Equipment Mfg. Industry Profile - CIC3544
5/31/2013 | published by: Beijing Zeefer Consulting Ltd.
China Medicine Production Equipment Mfg. Industry Profile - CIC3544 Through a comparative analysis on the development of medicine production equipment mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map,
|
read more...
|
$580.00
|
|
China Pharmaceutical Mfg. Industry Profile - CIC27
5/31/2013 | published by: Beijing Zeefer Consulting Ltd.
China Pharmaceutical Mfg. Industry Profile - CIC27 Through a comparative analysis on the development of pharmaceutical mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key
|
read more...
|
$580.00
|
|
Brazil Pharmaceuticals and Healthcare Report Q3 2013
6/12/2013 | published by: Business Monitor International
BMI View: The Brazilian government has become increasingly proactive in supporting localpharmaceutical industry. At a time when the public sector is trying to balance increasing demand forhealthcare with the need to control public healthcare spending,
|
read more...
|
$1,295.00
|
|
Bangladesh Pharmaceuticals and Healthcare Report Q3 2013
5/29/2013 | published by: Business Monitor International
BMI View: While Bangladesh has a substantial population of 152mn people, annual per capita expenditureon healthcare is very modest at just US$28. Despite expected economic progress, the majority of thepopulation will continue to have inadequate
|
read more...
|
$1,295.00
|
|
Canada Pharmaceuticals and Healthcare Report Q3 2013
5/29/2013 | published by: Business Monitor International
BMI View: The Canadian government's focus on further cost-containment policies to healthcare overlooksthe sector's function as a generator of wealth. Canada's healthcare sector, which receives 70% of itsfunding from the government, has absorbed labour forces
|
read more...
|
$1,295.00
|
|
Lebanon Pharmaceuticals and Healthcare Report Q3 2013
5/29/2013 | published by: Business Monitor International
BMI View: Although Lebanon's pharmaceutical market will remain largely valued by patented medicinesconsumption, we expect a swifter uptake in generic medicines over the 2012-2022 period. However, thisgeneric drug uptake is jeopardised by the ongoing Syrian
|
read more...
|
$1,295.00
|
|
Poland Pharmaceuticals and Healthcare Report Q3 2013
5/29/2013 | published by: Business Monitor International
BMI View: The Polish pharmaceutical market contracted severely in 2012 due to harsh pricing measuresand strict margins imposed on wholesalers, pharmaceutical manufacturers and retailers. Moreover, overthe course of the year, the burden of pharmaceutical spending
|
read more...
|
$1,295.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Cardiovascular Reports